Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...
Medtronic plc MDT recently announced two regulatory milestones for its MiniMed 780G system portfolio. The FDA has cleared the company’s SmartGuard algorithm as an interoperable automated glycemic ...
Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the biggest ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has approved an expanded indication for the ...
After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children and adults had an improvement in time in range ...
ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...
The US Food and Drug Administration has approved Medtronic Minimed's 780G automated insulin delivery system with the Guardian 4 sensor. The latest so-called artificial pancreas system is approved for ...
Wide-moat Medtronic received highly welcome news today as the U.S. Food and Drug Administration has (finally) approved the firm’s next-gen 780g insulin pump, and we’re leaving our $112 fair value ...
GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback